Crossmark

Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products

Crossref DOI link: https://doi.org/10.1208/s12248-021-00592-y

Published Online: 2021-04-21

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pawar, Gopal

Wu, Fang

Zhao, Liang

Fang, Lanyan

Burckart, Gilbert J.

Feng, Kairui

Mousa, Youssef M.

Naumann, Franci

Batchelor, Hannah K.
License Information

Text and Data Mining valid from 2021-04-21

Version of Record valid from 2021-04-21
More Information

Article History

Received: 6 January 2021

Accepted: 6 April 2021

First Online: 21 April 2021

Declarations

:

: The authors declare no competing interests.

: The opinions expressed in this article are those of the authors and should not be interpreted as the position of the U.S. FDA and the cases being presented do not imply FDA’s endorsement of the products.

Document is current

Any future updates will be listed below